Christine Hoang

BACKGROUND: The standard test for the diagnosis of acute rejection in kidney transplants is the renal biopsy. Noninvasive tests would be preferable. METHODS: We prospectively collected 4300 urine specimens from 485 kidney-graft recipients from day 3 through month 12 after transplantation. Messenger RNA (mRNA) levels were measured in urinary cells and correlated with allograft-rejection status with the use of logistic regression. RESULTS: A three-gene signature of 18S ribosomal (rRNA)-normalized measures of CD3ε mRNA and interferon-inducible protein 10 (IP-10) mRNA, and 18S rRNA discriminated between biopsy specimens showing acute cellular rejection and those not showing rejection (area under the curve [AUC], 0.85; 95% confidence interval [CI], 0.78 to 0.91; P<0.001 by receiver-operating-characteristic curve analysis). The cross-validation estimate of the AUC was 0.83 by bootstrap resampling, and the Hosmer-Lemeshow test indicated good fit (P=0.77). In an external-validation data set, the AUC was 0.74 (95% CI, 0.61 to 0.86; P<0.001) and did not differ significantly from the AUC in our primary data set (P=0.13). The signature distinguished acute cellular rejection from acute antibody-mediated rejection and borderline rejection (AUC, 0.78; 95% CI, 0.68 to 0.89; P<0.001). It also distinguished patients who received anti-interleukin-2 receptor antibodies from those who received T-cell-depleting antibodies (P<0.001) and was diagnostic of acute cellular rejection in both groups. Urinary tract infection did not affect the signature (P=0.69). The average trajectory of the signature in repeated urine samples remained below the diagnostic threshold for acute cellular rejection in the group of patients with no rejection, but in the group with rejection, there was a sharp rise during the weeks before the biopsy showing rejection (P<0.001). CONCLUSIONS: A molecular signature of CD3ε mRNA, IP-10 mRNA, and 18S rRNA levels in urinary cells appears to be diagnostic and prognostic of acute cellular rejection in kidney allografts. (Funded by the National Institutes of Health and others.).

PURPOSE: This study described and quantified the prevalence, timing, and intensity of pain during the expansion phase of rapid palatal expansion (RPE) in children and investigated whether pain was related to age, sex, or rate of expansion. METHODS: Ninety-seven children, 38 males and 59 females, between the ages of 5 to 13 years (median 7.7 years) undergoing RPE procedures with the Hyrax, Dentaurum, Newtown, PA, appliance were surveyed. The appliance was expanded with either one or two turns (1/4 mm/turn) per day based on the provider's preference. The child's pain response was measured no more than 5 minutes after each turn for the entire period of expansion using both the Facial Pain Scale and the Color Analog Scale. RESULTS: Ninety-eight percent of the children reported at least some pain during RPE. The highest levels of pain were reported during the first 10 turns with the greatest intensity during the first 6 turns and a steadily decreasing amount of pain thereafter. Pain medication was taken after 7% of the expansion turns in the study with the majority of children taking the medication during the first 6 turns. Forty-eight percent of the children took pain medication at least once during the expansion phase of RPE. There was no difference in either reported pain or use of pain medication based on age, sex, or stage of dentition. During the first 10 turns, children whose rate of expansion was two turns/day were more likely to report pain and take pain medication than children whose rate of expansion was one turn/day, thereafter there were no differences. CONCLUSIONS: The vast majority of children undergoing the active phase of rapid palatal expansion with a Hyrax appliance report pain. The pain generally occurs during the initial phase of expansion and diminishes thereafter, with two turns/day resulting in reports of pain greater than those expanding only once/day.

OBJECTIVE To identify knowledge and practices related to rabies vaccination and serologic monitoring among animal care workers in the United States. DESIGN Cross-sectional survey. SAMPLE 2,334 animal care workers (ie, veterinarians, veterinary technicians, animal control workers, and wildlife rehabilitators). PROCEDURES Participants were contacted through relevant professional organizations to participate in an anonymous web-based survey. The survey collected demographic and occupational information, animal handling and potential rabies exposure information, and individual rabies vaccination and serologic monitoring practices. Comparisons of animal bite and rabies exposure rates were made between occupational groups. Multiple logistic regression was used to evaluate factors associated with rabies vaccination status and adherence to serologic monitoring recommendations. RESULTS Respondents reported 0.77 animal bites/person-year or 0.10 bites/1,000 animals handled. The overall rate of postexposure prophylaxis due to an occupational rabies exposure was 1.07/100 person-years. Veterinarians reported the highest rabies vaccination rate (98.7% [367/372]), followed by animal control workers (78.5% [344/438]), wildlife rehabilitators (78.2% [122/156]), and veterinary technicians (69.3% [937/1,352]). Respondents working for employers requiring rabies vaccination and serologic monitoring were 32.16 and 6.14 times, respectively, as likely to be vaccinated or have a current serologic monitoring status as were respondents working for employers without such policies. CONCLUSIONS AND CLINICAL RELEVANCE Results suggested that, given the high reported rates of animal bites and potential rabies exposures among animal care workers, improvements in rabies vaccination and serologic monitoring practices are needed.

INTRODUCTION: The benefits of global health training in clinical education have been well described in graduate medical education literature. Despite these benefits there is a lack of global health training offered by OBGYN residency programs nationally. The purpose of the study is to assess prospective OBGYN residents’ interests and attitudes toward such training and the results can potentially help develop an educational curriculum and clinical training opportunity. METHODS: A survey was developed to assess prospective residents’ views on global health training. Questions utilized a Likert scale response. Additional questions included demographics and prior global health experience. The anonymous, voluntary survey was distributed to our OBGYN residency applicants who interviewed in 2016-2017. Univariate and bivariate analysis was conducted. Fisher exact tests and two-sided p values were calculated to determine statistically significant differences. RESULTS: The response rate was 50/62. 76% were likely to participate in an offered elective. 94% agreed that residencies should offer voluntary electives. 64% expressed interest in incorporating global health into future practices. Scheduling conflicts were perceived as the greatest barrier to participation. Learning about public health systems and gaining procedural experience were the main interests. Over 50% had prior global health experience. CONCLUSION: Findings suggest that applicants to our OBGYN residency believe a global health elective should be offered in residency training and a majority would participate if given the opportunity. With the strong interest and positive attitudes toward a global health elective, steps can be taken to develop a curriculum and training opportunity.